It was also found that overexpression of IL-17RB was associated with metastasis and poor clinical outcome of pancreatic cancer, and impairing IL-17B-IL-17RB signaling blocked metastasis of pancreatic cancer (Wu et al., 2015). Here, IL17B is linked to pancreatic neoplasm.